Literature DB >> 20828992

Off-label prescription of tigecycline: clinical and microbiological characteristics and outcomes.

David Conde-Estévez, Santiago Grau, Juan Pablo Horcajada, Sonia Luque.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20828992     DOI： 10.1016/j.ijantimicag.2010.07.006

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN： 0924-8579            Impact factor:   5.283


× No keyword cloud information.
  4 in total

1.  Ventilator-Associated Pneumonia (VAP) with Multidrug-Resistant (MDR) Pathogens: Optimal Treatment?

Authors:  Kristina L Bailey; Andre C Kalil
Journal:  Curr Infect Dis Rep       Date:  2015-08       Impact factor: 3.725

2.  How to treat VAP due to MDR pathogens in ICU patients.

Authors:  José Garnacho-Montero; Yael Corcia-Palomo; Rosario Amaya-Villar; Luis Martin-Villen
Journal:  BMC Infect Dis       Date:  2014-11-28       Impact factor: 3.090

3.  Coagulation dysfunction events associated with tigecycline: a real-world study from FDA adverse event reporting system (FAERS) database.

Authors:  Mingxing Guo; Jinwei Liang; Dandan Li; Ying Zhao; Wanyi Xu; Lei Wang; Xiangli Cui
Journal:  Thromb J       Date:  2022-03-05

Review 4.  Hypofibrinogenemia induced by high-dose tigecycline-case report and review of literature.

Authors:  Qiaomei Fan; Wei Huang; Yayun Weng; Xianze Xie; Zheng Shi
Journal:  Medicine (Baltimore)       Date:  2020-10-23       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.